ELIZABETH HOWARD: Open Payments
NPI 1649665118 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 64 payments from 20 companies in 2025. Trend: 2023 $225 · 2024 $489 · 2025 $1,158
Food & beverage: $1,158
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $196 |
| Lilly USA, LLC | 10 | $174 |
| Novo Nordisk Inc | 7 | $120 |
| Amgen Inc. | 5 | $92 |
| E.R. Squibb & Sons, L.L.C. | 4 | $76 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| PFIZER INC. | 4 | $65 |
| Exact Sciences Corporation | 2 | $44 |
| GlaxoSmithKline, LLC. | 3 | $43 |
Products named: UBRELVY, MOUNJARO, ELIQUIS, VRAYLAR, LEQVIO, OTEZLA, FARXIGA, Cologuard Collection Kit.
Industry payments across MO — which companies pay providers there.
